Literature DB >> 34048587

Optimal serum ferritin level range: iron status measure and inflammatory biomarker.

Ralph G DePalma1,2, Virginia W Hayes3, Timothy J O'Leary1,4.   

Abstract

This report provides perspectives concerning dual roles of serum ferritin as a measure of both iron status and inflammation. We suggest benefits of a lower range of serum ferritin as has occurred for total serum cholesterol and fasting blood glucose levels. Observations during a prospective randomized study using phlebotomy in patients with peripheral arterial disease offered unique insights into dual roles of serum ferritin both as an iron status marker and acute phase reactant. Robust positive associations between serum ferritin, interleukin 6 [IL-6], tissue necrosis factor-alpha, and high sensitivity C-reactive protein were discovered. Elevated serum ferritin and IL-6 levels associated with increased mortality and with reduced mortality at ferritin levels <100 ng mL-1. Epidemiologic studies demonstrate similar outcomes. Extremely elevated ferritin and IL-6 levels also occur in individuals with high mortality due to SARS-CoV-2 infection. Disordered iron metabolism reflected by a high range of serum ferritin level signals disease severity and outcomes. Based upon experimental and epidemiologic data, we suggest testing the hypotheses that optimal ferritin levels for cardiovascular mortality reduction range from 20 to 100 ng mL-1 with % transferrin levels from 20 to 50%, to ensure adequate iron status and that ferritin levels above 194 ng mL-1 associate with all-cause mortality in population cohorts. Published by Oxford University Press 2021.

Entities:  

Keywords:  Covid-19; atherosclerosis; ferritin; hyperferritinemic syndromes; inflammatory cytokines; iron metabolism

Mesh:

Substances:

Year:  2021        PMID: 34048587      PMCID: PMC8195161          DOI: 10.1093/mtomcs/mfab030

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  3 in total

1.  Iron Related Biomarkers Predict Disease Severity in a Cohort of Portuguese Adult Patients during COVID-19 Acute Infection.

Authors:  Ana C Moreira; Maria Jose Teles; Tânia Silva; Clara M Bento; Inês Simões Alves; Luisa Pereira; João Tiago Guimarães; Graça Porto; Pedro Oliveira; Maria Salomé Gomes
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

Review 2.  Therapeutic potential of induced iron depletion using iron chelators in Covid-19.

Authors:  Punnoth Poonkuzhi Naseef; Muhammed Elayadeth-Meethal; K T Mohammed Salim; A Anjana; C Muhas; K Abdul Vajid; Mohamed Saheer Kuruniyan
Journal:  Saudi J Biol Sci       Date:  2021-12-13       Impact factor: 4.052

Review 3.  Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Biomed Pharmacother       Date:  2021-11-12       Impact factor: 7.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.